Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study.

Saved in:
Bibliographic Details
Title: Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study.
Authors: Rodriguez-Labrada R; Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH), Holguín, Cuba.; Cuban Centre for Neurosciences, Havana, Cuba., Ortega-Sanchez R; Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH), Holguín, Cuba., Hernández Casaña P; Center of Molecular Immunology (CIM), Havana, Cuba., Santos Morales O; Center of Molecular Immunology (CIM), Havana, Cuba., Padrón-Estupiñan MDC; Otorhinolaryngology Department, 'Vladimir I. Lenin' General University Hospital, Holguín, Cuba., Batista-Nuñez M; Otorhinolaryngology Department, 'Octavio de la Concepción' Pediatric Hospital, Holguín, Cuba., Jiménez Rodríguez D; Center for Research and Development of drugs (CIDEM), Havana, Cuba., Canales-Ochoa N; Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH), Holguín, Cuba., Peña Acosta A; Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH), Holguín, Cuba., Medrano Montero J; Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH), Holguín, Cuba., Labrada Aguilera PE; Otorhinolaryngology Department, 'Octavio de la Concepción' Pediatric Hospital, Holguín, Cuba., Estupiñán Rodriguez A; Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH), Holguín, Cuba., Vazquez-Mojena Y; Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH), Holguín, Cuba.; Cuban Centre for Neurosciences, Havana, Cuba., Almaguer Gotay D; Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH), Holguín, Cuba., Aymed-García J; Center of Molecular Immunology (CIM), Havana, Cuba., García-García I; Center for Research and Development of drugs (CIDEM), Havana, Cuba., Torres Vega R; Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH), Holguín, Cuba., Viada González C; Center of Molecular Immunology (CIM), Havana, Cuba., Valenzuela Silva CM; Center of Molecular Immunology (CIM), Havana, Cuba., Silva Ricardo Y; 'Lucía Iñiguez Landín' Clinical Surgical Hospital, Holguín, Cuba., Columbié Ximelis J; 'Lucía Iñiguez Landín' Clinical Surgical Hospital, Holguín, Cuba., Tribin Rivero K; 'Lucía Iñiguez Landín' Clinical Surgical Hospital, Holguín, Cuba., Valle Cabrera R; National Center for the Coordination of Clinical Trials (CENCEC), Havana, Cuba., García-Rodriguez JC; National Center for Laboratory Animal Production, Havana, Cuba., Crombet Ramos T; Center of Molecular Immunology (CIM), Havana, Cuba., Amaro-González D; Center of Molecular Immunology (CIM), Havana, Cuba., Rodriguez-Obaya T; Center of Molecular Immunology (CIM), Havana, Cuba., Velázquez-Pérez L; Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH), Holguín, Cuba.; Cuban Academy of Sciences, Havana, Cuba.
Source: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2022 Jul; Vol. 37 (7), pp. 1516-1525. Date of Electronic Publication: 2022 May 23.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1531-8257
DOI:10.1002/mds.29045